Oncology & Hematology Associates of Southwest Virginia, Inc.,DBA Blue Ridge Cancer Care, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
Oncology & Hematology Associates of Southwest Virginia, Inc.,DBA Blue Ridge Cancer Care, Low Moor
e altri 4

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NEXT Oncology Virginia, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07277413

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

Virginia Oncology Associates (VOA) ( Site 8002), Norfolk

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

USO - Virginia Oncology Associates, Norfolk

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07218380

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Virginia Cancer Specialists, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07217171

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Potomac Urology, Alexandria
Urology of Virginia, Virginia Beach

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06567743

The Vanguard Study: Testing a New Way to Screen for Cancer

Sentara Martha Jefferson Hospital, Charlottesville
Inova Schar Cancer Institute, Fairfax
Inova Fair Oaks Hospital, Fairfax
e altri 5

In reclutamentoVolontari sani benvenuti

Età da 45 a 75 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06995898

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Chesapeake Regional Medical Center, Chesapeake
Augusta Health Center for Cancer and Blood Disorders, Fishersville
Bon Secours Memorial Regional Medical Center, Mechanicsville
e altri 7

In reclutamentoStudio osservazionaleVolontari sani benvenuti

Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT05334069

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Virginia Urology, Richmond

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05951179

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Norfolk

In reclutamentoFase 2/3

Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07129993

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Bon Secours Memorial Regional Medical Center, Mechanicsville
Bon Secours Saint Francis Medical Center, Midlothian
Bon Secours Saint Mary's Hospital, Richmond
e altri 1

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT07097142

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

University of Virginia Comprehensive Cancer Center, Charlottesville

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT04752722

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

VCU Massey Comprehensive Cancer Center, Richmond

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ago 2026 · NCT07000084

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

University of Virginia Health System, Charlottesville
Local Institution - 0188, Norfolk

In reclutamentoFase 2/3

Età 18 e oltre · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT07106762

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Falls Church

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Inova Schar Cancer Institute, Fairfax

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT04879329

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Virginia Cancer Specialists, Fairfax

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT04389632

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

NEXT Virginia, Fairfax

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 feb 2026 · NCT07030257

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Charlottesville

In reclutamentoStudio osservazionale

Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

University of Virginia, Charlottesville

In reclutamento

Età da 18 a 90 · Tutti i sessi · Aggiornato il 16 dic 2024 · NCT05790850

Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.